BREAKING NEWS
Launching 1st March 2023. Also check out: https://www.thailandmedical.news/
Estradiol is a type of estrogen, which is the female sex hormone secreted by the ovaries and required for many bodily processes.
Estradiol is used as a treatment for symptoms caused by the menopause such as vaginal dryness, burning, irritation and hot flushes. It is also used to prevent osteoporosis developing in women who have gone through the menopause and as a therapy for conditions such as ovarian failure that lead to a lack of natural estrogen in the body.
The use of estradiol in medications such as the contraceptive pill or hormone replacement therapy is associated with several adverse effects and some of these are described below:
In cases of prolonged use, the risk of the following side effects is also raised:
Skin related side effects include skin pigmentation, chloasma and melasma. Other skin effects include loss of scalp hair, erythema multiforme, erythema nodosum, hirsuitism (growth of body hair), itching and rash.
When taken orally, gastrointestinal side effects may develop including nausea, vomiting, bloating, diarrhea, water retention, jaundice, gall stones, gastritis, dyspepsia, pancreatitis, liver enlargement and liver tumors. Weight gain may also be noted in some women.
Estradiol medication can cause depression, mood swings, irritability, anger, dizziness and headaches. Epileptic patients may also experience worsening of seizures.
Some studies have reported that estrogen therapy is associated with an increased risk of endometrial cancer and breast cancer. Some research has shown that the risk of endometrial cancer is removed when progestins are administered in combination with the estrogen therapy.
Studies have demonstrated variable effects of estrogen therapy on cardiovascular factors. Some have shown that the treatment can cause altered lipid levels that reduce cardiovascular risk, while others have suggested the therapy can increase the risk of high blood pressure, especially when it is administered in high doses. Furthermore, the use of estrogens as noncontraceptives has been shown to increase the risk of nonfatal myocardial infarction in young females, particularly if they smoke, while other studies have suggested no such increase in risk exists.
Overall, research has generally demonstrated that favorable alterations in plasma lipids occur with the use of estrogen therapy. The treatment has been reported to cause a rise in the level of high-density lipoproteins (HDLs) and a decrease in the level of low-density lipoproteins (LDLs) and cholesterol. On the other hand, the therapy has been shown to cause hypercalcemia in patients with breast cancer and bone metastases, as well as pancreatitis in those with inherited lipoprotein disorders.
Reported adverse effects on the liver have included the development of liver cell adenomas, hepatocellular carcinoma, focal nodular hyperplasia and hepatic hemangiomas. Many of the studies that suggested an increased risk of hepatic tumors were based on populations of women who took oral contraceptives over long periods.
Adverse endocrine effects that have been reported include an increase in thyroxin-binding globulin that, in turn, leads to an increase in the serum total thyroid level and a decrease in T3 uptake. A decrease in fasting plasma glucose has also been observed.
Some studies have shown that estrogen therapy can lead to ocular side effects such as lens discomfort, altered corneal curvature and retinal vascular thrombosis.
Women who are pregnant should avoid the use of estradiol because it has been shown to cause birth defects.
Although a severe allergic reaction to estradiol is rare, immediate medical attention should be sought if symptoms such as a rash, dizziness, swelling, itching or breathing difficulty develop.